Ron C. Herings

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 126 publications

The ABOARD-RWD infrastructure: Using linked real-world data to study the diagnosis and management of dementia.

The ABOARD-RWD infrastructure: Using linked real-world data to study the diagnosis and management of dementia.

Journal: Journal of Alzheimer's disease : JAD
Published: March 30, 2026

Statistical analysis plan of the study titled "A deprescribing programme aimed to optimize blood glucose-lowering medication in older people with type 2 diabetes mellitus - the OMED2 study: a randomized controlled trial".

Statistical analysis plan of the study titled "A deprescribing programme aimed to optimize blood glucose-lowering medication in older people with type 2 diabetes mellitus - the OMED2 study: a randomized controlled trial".

Journal: Trials
Published: November 19, 2025

Feasibility of implementing an intervention in general practice for deprescribing of glucose-lowering medication in overtreated elderly.

Feasibility of implementing an intervention in general practice for deprescribing of glucose-lowering medication in overtreated elderly.

Journal: Family practice
Published: September 05, 2025

Type 2 diabetes monitoring and control in migrants and non-migrants: A population-based cohort study in primary care in the Netherlands.

Type 2 diabetes monitoring and control in migrants and non-migrants: A population-based cohort study in primary care in the Netherlands.

Journal: Primary care diabetes
Published: July 20, 2025

Risk of thrombosis with thrombocytopaenia syndrome (TTS) after vaccination with AZD1222: a European VAC4EU post-authorisation safety study.

Risk of thrombosis with thrombocytopaenia syndrome (TTS) after vaccination with AZD1222: a European VAC4EU post-authorisation safety study.

Journal: Vaccine
Published: May 30, 2025

Rates of SARS-CoV-2 Breakthrough Infection or Severe COVID-19 and Associated Risk Factors After Primary and Booster Vaccination Against COVID-19 in the Netherlands.

Rates of SARS-CoV-2 Breakthrough Infection or Severe COVID-19 and Associated Risk Factors After Primary and Booster Vaccination Against COVID-19 in the Netherlands.

Journal: Vaccines
Published: April 01, 2025

Clinical Profile and Treatment Patterns in Individuals with Type 2 Diabetes and Chronic Kidney Disease Who Initiate a GLP-1 Receptor Agonist: A Multinational Cohort Study.

Clinical Profile and Treatment Patterns in Individuals with Type 2 Diabetes and Chronic Kidney Disease Who Initiate a GLP-1 Receptor Agonist: A Multinational Cohort Study.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: January 06, 2025

Clinical Profile and Treatment Adherence in Patients with Type 2 Diabetes and Chronic Kidney Disease Who Initiate an SGLT2 Inhibitor: A Multi-cohort Study.

Clinical Profile and Treatment Adherence in Patients with Type 2 Diabetes and Chronic Kidney Disease Who Initiate an SGLT2 Inhibitor: A Multi-cohort Study.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: September 22, 2024

Inconsistency in ferritin reference intervals across laboratories: a major concern for clinical decision making.

Inconsistency in ferritin reference intervals across laboratories: a major concern for clinical decision making.

Journal: Clinical chemistry and laboratory medicine
Published: July 18, 2024

Women have a higher risk of hospital admission associated with hyponatremia than men while using diuretics.

Women have a higher risk of hospital admission associated with hyponatremia than men while using diuretics.

Journal: Frontiers in pharmacology
Published: March 29, 2024

A deprescribing programme aimed to optimise blood glucose-lowering medication in older people with type 2 diabetes mellitus, the OMED2-study: the study protocol for a randomised controlled trial.

A deprescribing programme aimed to optimise blood glucose-lowering medication in older people with type 2 diabetes mellitus, the OMED2-study: the study protocol for a randomised controlled trial.

Journal: Trials
Published: March 27, 2024

Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe.

Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe.

Journal: BMJ open
Published: March 26, 2024
Showing 1-12 of 126

Last Updated: 09/26/2026